§ Claim under review · Study
"A study of over 40,000 adults over 9.8 years, published in the European Heart Journal (2025), found that morning-only coffee drinkers had a 16% lower risk of death from any cause and a 31% lower risk of death from cardiovascular disease compared to non-coffee drinkers." Image overlay: "MORNING COFFEE DRINKERS HAD 16% LOWER OVERALL MORTALITY AND 31% LOWER HEART DISEASE RISK."
Verdict
Unverified
Confidence
HighSummary
The study behind this post is real and the numbers are accurate. A paper in the European Heart Journal in 2025 followed 40,725 US adults for a median of 9.8 years and found that people whose coffee drinking was concentrated in the morning had about 16 percent lower all-cause death rates and about 31 percent lower cardiovascular death rates than people who drank no coffee, while all-day coffee drinkers showed no significant reduction. However, this was an observational study, and the authors state plainly that it cannot show cause and effect. The post's explanations about coffee syncing with your circadian clock, suppressing melatonin, raising cortisol, or reducing inflammation were not measured in this study and are hypotheses, not findings. The image caption also says "31 percent lower heart disease risk," when the actual finding was about death from cardiovascular disease, not the chance of developing heart disease. Coffee timing was measured from one or two days of self-reported diet recall, so it may not reflect lifelong habits, and people who drink no coffee at all may differ from coffee drinkers in ways the researchers could not fully account for. The bottom line is that the statistics are reported correctly but the confident cause-and-effect story built around them goes beyond what the evidence supports.
The readings
key figures from the evidencelower all-cause mortality, morning-type coffee drinkers
lower cardiovascular mortality, morning-type coffee drinkers
NHANES study participants
Why this verdict
Evidence
The study is real and the headline percentages match it. The study included 40,725 adults from NHANES 1999-2018 with complete dietary data, plus 1,463 adults from the Women's and Men's Lifestyle Validation Study with 7-day dietary records, and clustering analysis was used to identify coffee timing patterns.
Two patterns were identified, a morning type covering 36% of participants and an all-day type covering 14%, and during a median follow-up of 9.8 years there were 4,295 all-cause deaths, 1,268 cardiovascular deaths, and 934 cancer deaths. After adjustment for caffeinated and decaffeinated coffee intake amounts, sleep hours, and other confounders, the morning-type pattern was associated with lower risks of all-cause and cardiovascular disease mortality compared with non-coffee drinking, with hazard ratios of 0.84 and 0.69 respectively
, which correspond to the 16% and 31% figures. The ESC press release and the accompanying editorial confirm the same hazard ratios of 0.84 for all-cause mortality and 0.69 for cardiovascular mortality for the morning type rather than the all-day type.
The paper also reports a somewhat smaller estimate in a different model. The abstract states that compared with non-coffee drinking, a morning-type pattern was significantly associated with lower all-cause mortality risk (HR 0.88; 95% CI 0.81-0.96), whereas an all-day-type pattern was not associated with risk. The 16% figure therefore reflects the model additionally adjusted for coffee amount and sleep hours, which is the larger of the two published estimates.
Coverage confirms that people who drank coffee throughout the day did not have a statistically significant reduction in risk compared with non-coffee drinkers, and that higher coffee amounts were associated with lower mortality only among morning drinkers.
Findings
✓ What's accurate 7
- The journal, year, and study exist as described. European Heart Journal, 2025, Volume 46, Issue 8.
- "Over 40,000 adults" is correct: 40,725 NHANES participants.
- "9.8 years" is correct as the median follow-up.
- The 16% lower all-cause mortality figure matches the reported HR of 0.84.
- The 31% lower cardiovascular death figure matches the reported HR of 0.69.
- The comparison group was non-coffee drinkers, as stated.
- The claim that all-day drinkers did not show the same association is consistent with the paper.
≈ What's misleading 7
- Overlay wording error (imprecision changing meaning): the image says "31% LOWER HEART DISEASE RISK." The finding was about death from cardiovascular disease, not the risk of developing heart disease. The caption gets this right, the graphic does not.
- "Morning-only" (subgroup mislabeling): the study's "morning type" is a cluster with coffee intake concentrated in the morning, derived statistically from dietary recall data. It is not a group of people who verifiably never drink coffee after noon.
- Unsupported causal inference: the caption states coffee "works in sync with your body's natural rhythms," "can support healthy blood vessel function and reduce inflammation," and that later coffee "can disrupt melatonin, mess with your heart rate, and elevate stress hormones like cortisol, which may cancel out its earlier benefits." None of these were outcomes measured in this study. They are mechanistic hypotheses raised in discussion, and the editorial phrases them as possibilities.
- Absence of evidence framed as evidence of absence: "those who drank coffee throughout the entire day did not receive the same health benefits" translates a non-statistically-significant result in a smaller group (14% of participants) into a definitive statement of no benefit.
- Omitted qualifier: the post never states that this is an observational study that cannot establish cause and effect, which is the single most important caveat the authors themselves emphasize.
- Relative risk without absolute risk: 16% and 31% are relative reductions. The absolute difference in death rates over a decade is much smaller and is not conveyed.
- Model selection: the paper contains both a 12% (HR 0.88) and a 16% (HR 0.84) all-cause estimate. The post uses only the larger one without noting it comes from the more heavily adjusted model.
? What's uncertain 4
- Whether the paper reports a formally significant direct statistical comparison between morning-type and all-day-type mortality hazard ratios. I confirmed a reported interaction between coffee amount and timing for all-cause mortality, but I did not retrieve a head-to-head significance test between the two timing clusters, so the strength of the "morning beats all-day" contrast cannot be graded as high certainty.
- The exact 95% confidence interval for the cardiovascular hazard ratio of 0.69 was not retrieved in the sources I reviewed.
- How well one or two days of dietary recall represent lifelong coffee habits is unknown and is a structural weakness of the exposure measure.
- Whether non-coffee drinkers in NHANES were systematically less healthy at baseline, for example having quit coffee due to illness, cannot be resolved from the abstract level material retrieved.
Sources
3 of 5 linked to recordsWang X, Ma H, Sun Q, Li J, Heianza Y, Van Dam RM, Hu FB, Rimm E, Manson JE, Qi L. "Coffee drinking timing and mortality in US adults." European Heart Journal, Vol 46, Issue 8, 21 Feb 2025, pp 749-759 (published online 8 Jan 2025). Primary, peer-reviewed journal article. https://academic.oup.com/eurheartj/article/46/8/749/7928425 and https://pmc.ncbi.nlm.nih.gov/articles/PMC11843000/
Lüscher TF. "Start your day with a morning coffee!" European Heart Journal invited editorial, Vol 46, Issue 8, pp 760-762. Primary commentary, peer-reviewed journal. https://academic.oup.com/eurheartj/article/46/8/760/7928645
European Society of Cardiology press release, "Morning coffee may protect the heart better than all-day coffee drinking." Primary institutional communication. https://www.escardio.org/news/press/press-releases/morning-coffee-may-protect-the-heart-better-than-all-day-coffee-drinking/
PubMed record, 39776171. Primary index with exposure definitions. https://pubmed.ncbi.nlm.nih.gov/39776171/
HealthDay / Pulmonology Advisor and PsyPost coverage, including author and independent dietitian comments. Secondary journalism citing the primary study.